-1-


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): March 23, 2005


                                DATIGEN.COM, INC.
                                -----------------
             (Exact name of registrant as specified in its charter)

            Utah                    0-26027                 87-0626333
            ----                    -------                 ----------
(State or other jurisdiction     (Commission             (IRS Employer
of incorporation)                File Number)            Identification No.)


                          c/o David Lubin & Associates
                              92 Washington Avenue
                              Cedarhurst, NY 11516
                              --------------------
                    (Address of principal executive offices)

                                 (516) 569-9629
                                 --------------
              (Registrant's telephone number, including area code)

                                 ---------------
         (Former name or former address, if changed since last report.)

<PAGE>
                                      -2-


Section 1- Registrant's Business and Operations

Item 1.01 Entry into a Material Definitive Agreement

The disclosure set forth under 2.01 (Completion of Acquisition or Disposition of
Assets)  and Item  3.02  (Unregistered  Sales of  Equity  Securities)  is hereby
incorporated by reference into this Item 1.01.

Section 2- Financial Information

Item 2.01 Completion of Acquisition or Disposition of Assets

As previously  reported,  Datigen.com,  Inc. (the  "Registrant")  entered into a
binding letter of intent (the "Letter of Intent") with Purisys, Inc., New Jersey
corporation ("Purisys") which provided,  among other things, for the sale to the
Registrant of all of the assets  constituting the Battery Brain product owned by
Purisys.  See the Current Reports on Form 8-K filed by the Registrant on each of
December 17, 2004 and March 1, 2005.

On March 23, 2005,  the  Registrant,  Purisys and Aharon Y. Levinas  ("Levinas")
executed an Asset  Purchase  Agreement (the  "Agreement")  pursuant to which the
Registrant purchased all the intellectual property relating to the Battery Brain
product and the  goodwill  associated  therewith  and  certain of the  equipment
relating to the product. The consideration paid by the Registrant for the assets
was the issuance to Levinas,  the sole shareholder of Purisys,  of the number of
shares of common stock, no par value, of the Registrant  ("Common  Stock") which
will  constitute,  as of March 23, 2005,  twenty (20%) percent of all issued and
outstanding Common Stock and $100,000, which was previously paid pursuant to the
Letter of  Intent.The  purchased  assets did not  include  the  inventory  which
existed  as of March 23,  2005 or the molds for the  Battery  Brain  (which  are
currently  in Italy and  China),  which were  purchased  by the  Registrant  for
$66,487.

The Registrant and Levinas shall mutually agree to negotiate,  in good faith, an
agreement regarding the registration rights of the Levinas for the shares issued
to  Levinas  pursuant  to the  Agreement;  Levinas  shall be  entitled  to equal
registration  rights with the controlling  shareholders  of the Registrant,  pro
rata in accordance with their holdings in the  Registrant,  subject to a lock-up
agreement.  The shares  will be issued to Levinas as soon as the  Registrant  is
duly authorized to do so.

The only  liabilities  assumed by the Registrant in the  transaction are (i) the
warranties and service of any Battery Brain products sold prior to the execution
and delivery of the  Agreement,  (ii) any potential  claims made by a person who
alleges that he assisted in  developing  the Battery Brain product and (iii) any
taxes incurred as a result of the  Agreement.  If there are any taxes imposed on
Purisys  and/or  Levinas  as a  result  of  the  receipt  of the  shares  of the
Registrant,  the Registrant  agreed to lend them the amount of  liabilities  and
expenses owed as a result  thereof.  Said loan shall be for a period of not less
than 10 years.


<PAGE>
                                      -3-

Pursuant to the terms of the Agreement, the Board of Directors of the Registrant
shall consist of five (5) members,  and Levinas shall be entitled to appoint 40%
of the representatives to the Board of Directors.

In  addition,  within the next two years the  Registrant  agreed to use its best
efforts to (a) consummate an equity raise of not less than $1,500,000 dollars at
a post-money valuation of not less than $12,000,000;  provided,  that all equity
raises  within 120 days  after  March 23,  2005 which are based on a  post-money
valuation  which  is  $10,500,000  or  greater,  shall  be  counted  toward  the
$1,500,000;  or (b)  generate  revenue  for the  Battery  Brain  product  in the
aggregate amount of $2,000,000. If the Registrant does not achieve either (a) or
(b) at any time on or prior to March 23, 2007, then Levinas shall be entitled to
receive  shares  in the  Registrant  which  equal 20% of the  outstanding  share
capital of the Registrant on a fully-diluted basis (calculated as of said date).

If the Registrant  shall for any reason cease to manufacture,  sell or otherwise
cease to be involved in the Battery Brain  product,  then Levinas shall have the
right to purchase the Battery Brain product from the  Registrant.  The price and
other terms of such right shall be negotiated between the parties.

The asset acquisition was consummated in accordance with Section 368(a)(1)(C) of
the Internal Revenue Code of 1986, as amended, as a tax-free reorganization.

For all the terms and conditions of the  Agreement,  reference is hereby made to
such  agreement  annexed  hereto as Exhibit  10.3.  All  statements  made herein
concerning the foregoing agreement are qualified by references to said exhibit.

Section 3 - Securities and Trading Markets

Item 3.02 Unregistered Sales of Equity Securities.

The disclosure set forth under 2.01 (Completion of Acquisition or Disposition of
Assets) is hereby incorporated by reference into this Item 3.02.

Section 5 - Corporate Governance and Management

Item 5.01 Changes in Control of Registrant

The disclosure set forth under 2.01 (Completion of Acquisition or Disposition of
Assets) is hereby incorporated by reference into this Item 5.01.


<PAGE>
                                      -4-


Item 5.02 Departure of Directors or Principal  Officers;  Election of Directors;
          Appointment of Principal Officers.

In  connection  with the  acquisition  of the Battery Brain assets from Purisys,
Levinas and his son,  Tamir Levinas were  appointed to the Board of Directors of
the  Registrant.  Robert Lubin resigned as a director of the Registrant on March
22, 2005. Said  resignation was made for personal reasons and not because of any
disagreement with the Registrant.

In connection with the acquisition of the assets from Purisys by the Registrant,
Levinas was also appointed as the Chief  Technology  Officer of the  Registrant.
The Registrant  agreed to employ Levinas as a consultant to the Registrant for a
4-year term, with a base salary of $160,000, $200,000, $240,000 and $240,000 for
each year of the term.  All benefits to be granted to the individual who will be
appointed as the Chief Executive  Officer of the Registrant  shall be granted to
Levinas as well,  including  bonuses and stock options.  Levinas shall receive a
cell  phone  and a car  allowance.  Pursuant  to the  terms  of  the  Consulting
Agreement,  Levinas is  subject  to  standard  confidentiality  and  non-compete
provisions.

The  consulting  agreement  with Levinas  provides that if Levinas is terminated
during the 4-year  term,  or is no longer  employed  by the  Registrant  for any
reason  during  said  period,  including  termination  for cause or  death,  the
Registrant  remains  obligated  to pay the full  amount of payment  due  Levinas
thereunder.

For all the terms and  conditions  of the  Consulting  Agreement,  reference  is
hereby made to such  agreement  annexed  hereto as Exhibit 10.4.  All statements
made herein  concerning  the foregoing  agreement are qualified by references to
said exhibit.

Business Experience

The following is a brief  account of the  education  and business  experience of
each director and executive  officer  during the past five years,  and any other
directorships held in reporting companies.

Aharon Y. Levinas was appointed as the Chief  Technology  Officer and a director
of the Registrant as of March 23, 2005.  Mr. Levinas is the sole  shareholder of
Purisys,  Inc., a New Jersey  corporation which Mr. Levinas  established over 10
years ago. Mr. Levinas' sole business  activities for the last 10 years has been
the development and establishment of the Batter Brain product.

Tamir Levinas, age 33, was appointed as a director of the Registrant as of March
23,  2005.  Since  ___ 1998 he has been the  head of  Technical  Development  of
Internet Gold (Nasdaq:  IGLD),  where he is responsible for managing all aspects
of the technical department activities,  project management and engineering,  as
well as being  responsible for technical vendor  relations and procurement.  Mr.
Levinas received a B.A. in Business and Information  Technology  Management from
Inter-Disciplinary Center in Herzelia, Israel in 2004.

<PAGE>
                                      -5-


Aharon Levinas is the father of Tamir Levinas.

There is no transaction during the last two years, or any proposed transactions,
to which the Registrant was or is a party with any of the foregoing  individuals
or any  member of their  respective  immediate  family  other than the Letter of
Intent and the Agreement.

Section 9-Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits

      (a) Financial statements of business acquired.

      (b) Pro forma financial information.

      The  financial  information  required  hereunder  will be  submitted by an
      amendment to this Current  Report on Form 8-K within 71 calendar days from
      the date of this Report.

      (c) Exhibits

      Exhibit 10.3 Asset  Purchase  Agreement,  dated as of March 23, 2005 among
                   Purisys, Inc. and the Registrant


      Exhibit 10.4 Consulting  Agreement dated as of March 23, 2005 between the
                   Registrant and Aharon Y. Levinas


<PAGE>
                                      -6-


                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                        DATIGEN.COM, INC.
                                        (Registrant)

                                        By: /s/ Amir Uziel
                                           -------------------------------------
                                           President and Chief Executive Officer

Date:  March 28, 2005
{"company-data": {"conformed-name": "DATIGEN COM INC", "cik": "0001086082", "assigned-sic": "6794", "irs-number": "870626333", "state-of-incorporation": "UT", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-26027", "film-number": "05707180"}, "business-address": {"street1": "887 WEST CENTER STREET", "city": "OREM", "state": "UT", "zip": "84057", "phone": "801-229-1288"}, "mail-address": {"street1": "887 WEST CENTER STREET", "city": "OREM", "state": "UT", "zip": "84057"}, "former-company": {"former-conformed-name": "ATOMIC GIANT COM INC", "date-changed": "19990510"}}
-1-

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): March 23, 2005

                                DATIGEN.COM, INC.
                                -----------------
             (Exact name of registrant as specified in its charter)

            Utah                    0-26027                 87-0626333
            ----                    -------                 ----------
(State or other jurisdiction     (Commission             (IRS Employer
of incorporation)                File Number)            Identification No.)

                          c/o David Lubin & Associates
                              92 Washington Avenue
                              Cedarhurst, NY 11516
                              --------------------
                    (Address of principal executive offices)

                                 (516) 569-9629
                                 --------------
              (Registrant's telephone number, including area code)

                                 ---------------
         (Former name or former address, if changed since last report.)
-2-

Section 1- Registrant's Business and Operations

Item 1.01 Entry into a Material Definitive Agreement

The disclosure set forth under 2.01 (Completion of Acquisition or Disposition of
Assets)  and Item  3.02  (Unregistered  Sales of  Equity  Securities)  is hereby
incorporated by reference into this Item 1.01.

Section 2- Financial Information

Item 2.01 Completion of Acquisition or Disposition of Assets

As previously  reported,  Datigen.com,  Inc. (the  "Registrant")  entered into a
binding letter of intent (the "Letter of Intent") with Purisys, Inc., New Jersey
corporation ("Purisys") which provided,  among other things, for the sale to the
Registrant of all of the assets  constituting the Battery Brain product owned by
Purisys.  See the Current Reports on Form 8-K filed by the Registrant on each of
December 17, 2004 and March 1, 2005.

On March 23, 2005,  the  Registrant,  Purisys and Aharon Y. Levinas  ("Levinas")
executed an Asset  Purchase  Agreement (the  "Agreement")  pursuant to which the
Registrant purchased all the intellectual property relating to the Battery Brain
product and the  goodwill  associated  therewith  and  certain of the  equipment
relating to the product. The consideration paid by the Registrant for the assets
was the issuance to Levinas,  the sole shareholder of Purisys,  of the number of
shares of common stock, no par value, of the Registrant  ("Common  Stock") which
will  constitute,  as of March 23, 2005,  twenty (20%) percent of all issued and
outstanding Common Stock and $100,000, which was previously paid pursuant to the
Letter of  Intent.The  purchased  assets did not  include  the  inventory  which
existed  as of March 23,  2005 or the molds for the  Battery  Brain  (which  are
currently  in Italy and  China),  which were  purchased  by the  Registrant  for
$66,487.

The Registrant and Levinas shall mutually agree to negotiate,  in good faith, an
agreement regarding the registration rights of the Levinas for the shares issued
to  Levinas  pursuant  to the  Agreement;  Levinas  shall be  entitled  to equal
registration  rights with the controlling  shareholders  of the Registrant,  pro
rata in accordance with their holdings in the  Registrant,  subject to a lock-up
agreement.  The shares  will be issued to Levinas as soon as the  Registrant  is
duly authorized to do so.

The only  liabilities  assumed by the Registrant in the  transaction are (i) the
warranties and service of any Battery Brain products sold prior to the execution
and delivery of the  Agreement,  (ii) any potential  claims made by a person who
alleges that he assisted in  developing  the Battery Brain product and (iii) any
taxes incurred as a result of the  Agreement.  If there are any taxes imposed on
Purisys  and/or  Levinas  as a  result  of  the  receipt  of the  shares  of the
Registrant,  the Registrant  agreed to lend them the amount of  liabilities  and
expenses owed as a result  thereof.  Said loan shall be for a period of not less
than 10 years.
-3-

Pursuant to the terms of the Agreement, the Board of Directors of the Registrant
shall consist of five (5) members,  and Levinas shall be entitled to appoint 40%
of the representatives to the Board of Directors.

In  addition,  within the next two years the  Registrant  agreed to use its best
efforts to (a) consummate an equity raise of not less than $1,500,000 dollars at
a post-money valuation of not less than $12,000,000;  provided,  that all equity
raises  within 120 days  after  March 23,  2005 which are based on a  post-money
valuation  which  is  $10,500,000  or  greater,  shall  be  counted  toward  the
$1,500,000;  or (b)  generate  revenue  for the  Battery  Brain  product  in the
aggregate amount of $2,000,000. If the Registrant does not achieve either (a) or
(b) at any time on or prior to March 23, 2007, then Levinas shall be entitled to
receive  shares  in the  Registrant  which  equal 20% of the  outstanding  share
capital of the Registrant on a fully-diluted basis (calculated as of said date).

If the Registrant  shall for any reason cease to manufacture,  sell or otherwise
cease to be involved in the Battery Brain  product,  then Levinas shall have the
right to purchase the Battery Brain product from the  Registrant.  The price and
other terms of such right shall be negotiated between the parties.

The asset acquisition was consummated in accordance with Section 368(a)(1)(C) of
the Internal Revenue Code of 1986, as amended, as a tax-free reorganization.

For all the terms and conditions of the  Agreement,  reference is hereby made to
such  agreement  annexed  hereto as Exhibit  10.3.  All  statements  made herein
concerning the foregoing agreement are qualified by references to said exhibit.

Section 3 - Securities and Trading Markets

Item 3.02 Unregistered Sales of Equity Securities.

The disclosure set forth under 2.01 (Completion of Acquisition or Disposition of
Assets) is hereby incorporated by reference into this Item 3.02.

Section 5 - Corporate Governance and Management

Item 5.01 Changes in Control of Registrant

The disclosure set forth under 2.01 (Completion of Acquisition or Disposition of
Assets) is hereby incorporated by reference into this Item 5.01.
-4-

Item 5.02 Departure of Directors or Principal  Officers;  Election of Directors;
          Appointment of Principal Officers.

In  connection  with the  acquisition  of the Battery Brain assets from Purisys,
Levinas and his son,  Tamir Levinas were  appointed to the Board of Directors of
the  Registrant.  Robert Lubin resigned as a director of the Registrant on March
22, 2005. Said  resignation was made for personal reasons and not because of any
disagreement with the Registrant.

In connection with the acquisition of the assets from Purisys by the Registrant,
Levinas was also appointed as the Chief  Technology  Officer of the  Registrant.
The Registrant  agreed to employ Levinas as a consultant to the Registrant for a
4-year term, with a base salary of $160,000, $200,000, $240,000 and $240,000 for
each year of the term.  All benefits to be granted to the individual who will be
appointed as the Chief Executive  Officer of the Registrant  shall be granted to
Levinas as well,  including  bonuses and stock options.  Levinas shall receive a
cell  phone  and a car  allowance.  Pursuant  to the  terms  of  the  Consulting
Agreement,  Levinas is  subject  to  standard  confidentiality  and  non-compete
provisions.

The  consulting  agreement  with Levinas  provides that if Levinas is terminated
during the 4-year  term,  or is no longer  employed  by the  Registrant  for any
reason  during  said  period,  including  termination  for cause or  death,  the
Registrant  remains  obligated  to pay the full  amount of payment  due  Levinas
thereunder.

For all the terms and  conditions  of the  Consulting  Agreement,  reference  is
hereby made to such  agreement  annexed  hereto as Exhibit 10.4.  All statements
made herein  concerning  the foregoing  agreement are qualified by references to
said exhibit.

Business Experience

The following is a brief  account of the  education  and business  experience of
each director and executive  officer  during the past five years,  and any other
directorships held in reporting companies.

Aharon Y. Levinas was appointed as the Chief  Technology  Officer and a director
of the Registrant as of March 23, 2005.  Mr. Levinas is the sole  shareholder of
Purisys,  Inc., a New Jersey  corporation which Mr. Levinas  established over 10
years ago. Mr. Levinas' sole business  activities for the last 10 years has been
the development and establishment of the Batter Brain product.

Tamir Levinas, age 33, was appointed as a director of the Registrant as of March
23,  2005.  Since  ___ 1998 he has been the  head of  Technical  Development  of
Internet Gold (Nasdaq:  IGLD),  where he is responsible for managing all aspects
of the technical department activities,  project management and engineering,  as
well as being  responsible for technical vendor  relations and procurement.  Mr.
Levinas received a B.A. in Business and Information  Technology  Management from
Inter-Disciplinary Center in Herzelia, Israel in 2004.
-5-

Aharon Levinas is the father of Tamir Levinas.

There is no transaction during the last two years, or any proposed transactions,
to which the Registrant was or is a party with any of the foregoing  individuals
or any  member of their  respective  immediate  family  other than the Letter of
Intent and the Agreement.

Section 9-Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits

      (a) Financial statements of business acquired.

      (b) Pro forma financial information.

      The  financial  information  required  hereunder  will be  submitted by an
      amendment to this Current  Report on Form 8-K within 71 calendar days from
      the date of this Report.

      (c) Exhibits

      Exhibit 10.3 Asset  Purchase  Agreement,  dated as of March 23, 2005 among
                   Purisys, Inc. and the Registrant

      Exhibit 10.4 Consulting  Agreement dated as of March 23, 2005 between the
                   Registrant and Aharon Y. Levinas
-6-

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                        DATIGEN.COM, INC.
                                        (Registrant)

                                        By: /s/ Amir Uziel
                                           -------------------------------------
                                           President and Chief Executive Officer

Date:  March 28, 2005